More than 25 years ago, Šimaga et al. found that DPP3 is overexpressed in ovarian and endometrial cancer compared to normal tissue [90], and in a 2003 study, they found that the level and activity of DPP3 were correlated with the aggressiveness of primary ovarian carcinoma [91]. Here, DPP3 is linked to endometrial cancer.